References
- Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543(7645):378–384.
- Koh WJ, Greer BE, Abu-Rustum NR, et al. Cervical Cancer, Version 2.2015. J Natl Comprehensive Cancer Network. 2015;13(4):395–404.
- Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
- Nuranna L, Fahrudin A. Survival Rate of Cervical Cancer in National Referral Hospital in 2012–2014. Acta Medica Indonesiana. 2019;51(2):145–150.
- Grant MC. Carcinoma of the cervix – a tragic disease in South Africa. South African Med J = Suid-Afrikaanse Tydskrif Vir Geneeskunde. 1982;61(22):819–822.
- Small W, Jr., Bacon MA, Bajaj A, et al. Cervical cancer: a global health crisis. Cancer. 2017;123(13):2404–2412.
- Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer. 2010;10(8):550–560.
- Mao Z, Li H, Du B, et al. LncRNA DANCR promotes migration and invasion through suppression of lncRNA-LET in gastric cancer cells. Biosci Rep. 2017;37(6).
- Fan H, Ge Y, Ma X, et al. Long non-coding RNA CCDC144NL-AS1 sponges miR-143-3p and regulates MAP3K7 by acting as a competing endogenous RNA in gastric cancer. Cell Death Dis. 2020;11(7):521.
- Liang L, Fu J, Wang S, et al. MiR-142-3p enhances chemosensitivity of breast cancer cells and inhibits autophagy by targeting HMGB1. Acta Pharmaceutica Sinica B. 2020;10(6):1036–1046.
- Wang Q, Wei S, Zhou H, et al. MicroRNA-98 inhibits hepatic stellate cell activation and attenuates liver fibrosis by regulating HLF expression. Frontiers Cell Dev Biol. 2020;8:513.
- Zheng Y, Liu L, Shukla GC. A comprehensive review of web-based non-coding RNA resources for cancer research. Cancer Lett. 2017;407:1–8.
- Iyer MK, Niknafs YS, Malik R, et al. The landscape of long noncoding RNAs in the human transcriptome. Nat Genet. 2015;47(3):199–208.
- Yao RW, Wang Y, Chen LL. Cellular functions of long noncoding RNAs. Nat Cell Biol. 2019;21(5):542–551.
- Sun T, Ye H, Wu CL, et al. Emerging players in prostate cancer: long non-coding RNAs. Am J Clin Exp Urol. 2014;2(4):294–299.
- Ma Y, Zhang J, Wen L, et al. Membrane-lipid associated lncRNA: a new regulator in cancer signaling. Cancer Lett. 2018;419:27–29.
- Ma YS, Chu KJ, Ling CC, et al. Long noncoding RNA OIP5-AS1 promotes the progression of liver hepatocellular carcinoma via regulating the hsa-miR-26a-3p/EPHA2 axis. Mol Ther Nucleic Acids. 2020;21:229–241.
- Chen LY, Zhang XM, Han BQ, et al. Long noncoding RNA SNHG12 indicates the prognosis and accelerates tumorigenesis of diffuse large B-Cell lymphoma through sponging microR-195. OncoTargets Therapy. 2020;13:5563–5574.
- Duan DM, Zhang L, Hua F. LncRNA UCA1 inhibits proliferation and promotes apoptosis of cervical cancer cells by regulating β-catenin/TCF-4. Eur Rev Med Pharmacol Sci. 2020;24(11):5963–5969.
- Liu Y, Guo R, Qiao Y, et al. LncRNA NNT-AS1 contributes to the cisplatin resistance of cervical cancer through NNT-AS1/miR-186/HMGB1 axis. Cancer Cell Int. 2020;20:190.
- Guo Q, Li L, Bo Q, et al. Long noncoding RNA PITPNA-AS1 promotes cervical cancer progression through regulating the cell cycle and apoptosis by targeting the miR-876-5p/c-MET axis. Biomed Pharmacother = Biomedecine & Pharmacotherapie. 2020;128:110072.
- Liao T, Maierdan SL, Lv C. ROR1-AS1 promotes tumorigenesis of colorectal cancer via targeting Wnt/β-catenin. Eur Rev Med Pharmacol Sci. 2019;23(3 Suppl):217–223.
- Chen Q, Fu L. Upregulation of long non-coding RNA ROR1-AS1 promotes cell growth and migration in bladder cancer by regulation of miR-504. PloS One. 2020;15(1):e0227568.
- Xu N, Qiao L, Yin L, et al. Long noncoding RNA ROR1-AS1 enhances lung adenocarcinoma metastasis and induces epithelial-mesenchymal transition by sponging miR-375. J BUON. 2019;24(6):2273–2279.
- Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505(7483):344–352.
- Qi X, Zhang DH, Wu N, et al. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015;52(10):710–718.
- Zhang Z, Qian W, Wang S, et al. Analysis of lncRNA-Associated ceRNA network reveals potential lncRNA biomarkers in human colon adenocarcinoma. Cell Physiol Biochem. 2018;49(5):1778–1791.
- Xu J, Yang B, Wang L, et al. LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression. Cell Prolif. 2020;53(7):e12823.
- Wen D, Huang Z, Li Z, et al. LINC02535 co-functions with PCBP2 to regulate DNA damage repair in cervical cancer by stabilizing RRM1 mRNA. J Cell Physiol. 2020;235(10):7592–7603.
- Iqbal MA, Arora S, Prakasam G, et al. MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance. Mol Aspects Med. 2019;70:3–20.
- Guoping M, Ran L, Yanru Q. miR-143 inhibits cell proliferation of gastric cancer cells through targeting GATA6. Oncol Res. 2018;26(7):1023–1029.
- Liu B, Tian Y, Li F, et al. Tumor-suppressing roles of miR-214 and miR-218 in breast cancer. Oncol Rep. 2016;35(6):3178–3184.
- Zhang W, Tang G, Zhou S, et al. LncRNA-miRNA interaction prediction through sequence-derived linear neighborhood propagation method with information combination. BMC Genomics. 2019;20(Suppl 11):946.
- Song J, Ye A, Jiang E, et al. Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network based on competitive endogenous RNA in CESC. J Cell Biochem. 2018;119(8):6665–6673.
- Fu Y, Cai L, Lei X, et al. Circular RNA ABCB10 promotes hepatocellular carcinoma progression by increasing HMG20A expression by sponging miR-670-3p. Cancer Cell Int. 2019;19:338.
- Kim PH, Na SS, Lee B, et al. Stanniocalcin 2 enhances mesenchymal stem cell survival by suppressing oxidative stress. BMB Rep. 2015;48(12):702–707.
- Lin C, Sun L, Huang S, et al. STC2 is a potential prognostic biomarker for pancreatic cancer and promotes migration and invasion by inducing epithelial-mesenchymal transition. BioMed Research International. 2019;2019:8042489.
- Ferreira do Carmo A, Dourado MR, Ervolino de Oliveira C, et al. Stanniocalcin 2 contributes to aggressiveness and is a prognostic marker for oral squamous cell carcinoma. Exp Cell Res. 2020;393(2):112092.
- Xue K, Li J, Nan S, et al. Downregulation of LINC00460 decreases STC2 and promotes autophagy of head and neck squamous cell carcinoma by up-regulating microRNA-206. Life Sci. 2019;231:116459.